Pharmacokinetic scaling of SJ-8029, a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities, by species-invariant time methods
- 23 May 2003
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 24 (5) , 191-197
- https://doi.org/10.1002/bdd.352
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- ANALYSIS AND STABILITY OF A NOVEL ANTICANCER AGENT, SJ-8029, POSSESSING MICROTUBULE AND TOPOISOMERASE INHIBITING ACTIVITIESAnalytical Letters, 2002
- Yeast cells expressing differential levels of human or yeast DNA topoisomerase II: a potent tool for identification and characterization of topoisomerase II-targeting antitumour agentsCancer Chemotherapy and Pharmacology, 1998
- Physiological Parameters in Laboratory Animals and HumansPharmaceutical Research, 1993
- Interspecies scaling and comparisons in drug development and toxicokineticsXenobiotica, 1990
- Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative ParadigmDrug Metabolism Reviews, 1984
- Animal scale-upJournal of Pharmacokinetics and Biopharmaceutics, 1973